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Corticosteroids (CS) contribute to muscle dysfunction by inducing transcription factors activating different proteolytic pathway genes leading to muscle fiber atrophy (3, 14, 29) . In an attempt to improve our understanding of the molecular mechanisms underlying corticosteroid involvement in ICU patients, the porcine ICU model was used in 5-day longitudinal experiments. Animals were exposed to immobilization due to sedation, MV, and systemic hydrocortisone administration and were compared with previous DNA microarray analysis of biceps femoris muscle from pigs exposed to immobilization by sedation and MV alone for 5 days (6) . In this setting, it was hypothesized that CS administration would potentiate the activation of proteolytic pathways, causing the decreased force generating capacity previously reported in response to CS administration in combination with immobilization and MV (26) . However, gene array analysis did not reveal any significant additional activation of proteolytic pathways when CS was added to the ICU intervention. On the other hand, an increased gene expression of eukaryotic translation initiation factor 4E binding protein (EIF4EBP1) and a decreased gene expression of eukaryotic translation initiation factor 4E (EIF4E) suggest decreased protein synthesis. Furthermore, systemic hydrocortisone administration induced changes in the regulation of kinase activity, oxidative stress response and heat shock protein (HSP) expression are suggested to play an instrumental role for the impaired muscle function in the ICU setting.
MATERIALS AND METHODS

Animals and Tissue Collection
Eight female domestic piglets (Sus scrofa, mean body wt 26.4 Ϯ 2.2 kg) were used in this study. Four animals in a control group and four animals in the CS group were used. All animals were monitored 24 h per day during the entire experimental period. All piglets originated from the same farm (Vallrums Lantbruk, Ransta, Sweden) and were kept in 12-square-meter pens with hay, straw, and wood shavings as bedding material. They were housed at 18 -19°C and relative humidity of 45-55% under natural day-night rhythm with liberal access to feed (Smågrisfoder Solo 331; Lantmannen, Stockholm, Sweden), water, and environmental enrichment. Food, but not water, was withheld for 12 h before induction of anesthesia. Initially, the pigs were sedated with medetomidine (Dormitor vet 1 mg/ml; Orion Pharma, Stockholm, Sweden) and zolazepam (Zoletil 250; Reading, Carros, France) before intravenous access was put in place and anaesthesia was induced with 100 mg iv ketamine (Ketaminol vet 50 mg/ml; Intervet, Boxneer, Netherlands). Following tracheostomy, all animals were mechanically ventilated by volume-controlled ventilation (Siemens 900A ventilator; Siemens Elema, Solna, Sweden) adjusted to an initial FiO 2 of 0.21-0.30, an inspired tidal volume of 10 ml/kg, and a respiratory rate of 20 breaths/min, with an I:E ratio of 1:2 and inspiratory rise time of 5-10%. During the remaining study period, the ventilator settings were adjusted to maintain systemic normoxia and normocarbia to avoid high airway pressures and risk of barotrauma. Sedation was titrated to promote immobilization and allow ventilator synchrony by inhibiting spontaneous breathing activity through a novel anesthetic conserving device (AnaConda; Sedana Medical, Sundbyberg, Sweden) that permits administration of an inhaled anesthetics via a syringe pump to the inspired gas mixture, as previously described (28) . During this study period, isoflurane (Abbott Laboratories, Chicago, IL) was delivered at 0.8 -1.3% end-tidal concentration and supplemented by intravenous bolus doses of morphine and ketamine as needed to provide immobilization. Core body temperature (blood) was maintained in the range of 38.5-40°C by a servo-controlled heating pad. Animals received a continuous intravenous infusion of a crystalloid solution (Ringeracetat; Fresenius Kabi, Stockholm, Sweden) at 2,000 -4,000 ml per day to maintain stable blood pressure and urinary output throughout the experimental period. An intravenous glucose infusion (25 mg glucose/ml, Rehydrex, Fresenius Kabi) at 1-1.5 ml·kg Ϫ1 ·h Ϫ1 was titrated to maintain blood glucose between 4 and 8 mmol/l to decrease the effects of catabolism. In addition, each animal received prophylactic streptomycin 750 mg/ day and bensylpenicillin 600 mg/day (Streptocillin Vet, BoeringerIngelheim, Hellerup, Denmark). Arterial oxygen and carbon dioxide tensions, acid-base balance, electrolytes, and blood glucose levels were monitored regularly and kept within normal range throughout the study period. CS was given as 50 mg bolus doses of hydrocortisone (Solu-Cortef, Pfizer) three times daily for 5 days. The Ethical Committee on Animal Research at the Karolinska Institute, Stockholm, Sweden, approved the study protocol (Dnr N71/98, N54/02, and N75/04).
Muscle Biopsies
Muscle biopsies of the biceps femoris were obtained from the animals on day 5 in both control and CS group. The part of the biopsy used in this study was frozen in liquid propane cooled by liquid nitrogen and stored at Ϫ80°C for later analysis (13) .
Expression Profiling
Three micrograms of total RNA from the muscle samples were extracted and processed to generate biotin-labeled cRNA as previously described (8) . Each sample was then hybridized to Affymetrix Porcine Genome Array containing 23,937 probes representing 20,201 genes. Standard operating procedure and quality control were done as previously described (8) . Muscle samples from the animals on day 5 were profiled. All profiles have been made publicly accessible via National Center for Biotechnology Information Gene Expression Omnibus (GSE33037 and GSE37166, http://www.ncbi.nlm.nih.gov/ geo).
Microarray Data Normalization and Analysis
Subsequent analysis of the gene expression data was carried out in the freely available statistical computing language R (http:// www.ncbi.nlm.nih.gov/geo) using packages available from the Bioconductor project (http://www.bioconductor.org). The raw data were normalized with the robust multiarray average (19) backgroundadjusted, normalized and log-transformed summarized values first suggested by Li and Wong in 2001 (23) . To search for the differentially expressed genes between the samples from the different days, we applied an empirical Bayes moderated t-test (33), using the "limma" package. A linear model was fitted to the data; day 5 vs. day 5 effects were estimated. To address the problem with multiple testing, we adjusted the P values according to Benjamini and Hochberg. Significant probe sets with an adjusted P value Ͻ 0.05 were selected for further investigation and more than a twofold change were included in further analyses. Since the porcine array is minimally annotated and is not identified by web-based analysis software, we used published putative human homologs (35) . Up-and downregulated transcripts were further analyzed and categorized using the DAVID web-based functional annotation tool (http://david.abcc.ncifcrf.gov/) (18) . Some of the functional categories were combined, and some categorization was done manually, to improve the interpretative value of the data. Clustering images were developed using Genesis software (34) . Reactome (http://www. reactome.org) software was used to obtain the gene pathways listed in the Table 1 .
Quantitative Real-time RT-PCR
Reverse transcription and quantitative PCR analysis was performed as previously described (25) . Briefly, total RNA (100 ng) was reverse transcribed to cDNA using Qscript cDNA supermix (Quanta Biosciences). cDNA was amplified in triplicate using MyiQsingle color real-time PCR detection system (Bio-Rad Laboratories, Hercules, CA) and used to quantify the mRNA levels for porcine 4EBP1, ACVRIIB, SOD2, MAP1A, MYH7, and 18S. The thermal cycling conditions include 95°C for 9 min, followed by 50 cycles of amplification at 95°C for 15 s, followed by 60°C for 1 min. All experimental gene Ct values lie between 25 and 35 cycles, except 18S where nine cycles were analyzed. Each reaction was performed in a 25 l volume with 0.4 M of each primer and 0.2 M probe or SYBR green (1988123; Roche Diagnostics, Ulm, Germany). Primers were designed using the Primer Express program (Applied Biosystems, Foster City, CA). Porcine 18S gene was used as the internal control. Sequences for the primers are listed in Table 2 .
Immunoblotting SDS-PAGE was performed by using Mini-PROTEAN 3 Cell (Bio-Rad Laboratories, Hercules, CA). We used 5 g of total protein.
Electrophoresis was performed at 120 volts for 1 h 30 min; gels were subjected to polyvinylidene fluoride membranes (GE Healthcare), and the blot was transferred for 1 h at 350 mA current. Membranes were incubated with HSP 70 (SMC 100A/B; Stress Marq Biosciences, Victoria, BC, Canada), HSP 90 (AC88; Stressgen, Ann Arbor, MI), Atrogin-1 (AP2041, ECM Biosciences), 4EBP1 (53H11, Cell Signaling Technology), and actin (sc-1616; Santa Cruz Biotechnology, Santa Cruz, CA) primary antibodies. Protein detection was performed by incubating the membranes with secondary antibodies NA931, NA934 (GE Healthcare), and AP180P (Millipore, Billerica, MA) and using the ECL Advance Western blotting detection kit (RPN 2135, GE Healthcare) according to the manufacturer's instructions. Membranes were scanned, and intensity volumes were measured according to the manufacturer's instructions (LI-COR Biosciences UK). Signal intensities were normalized to actin signal intensity.
Statistical Analysis
Data are presented as means Ϯ SE. Sigma Stat software (Jandel Scientific) was used to generate descriptive statistics, and t-test was used to test the statistical significance.
RESULTS
Gene Expression
Gene expression data from each biopsy sample were acquired by an unsupervised hierarchical clustering method; the data are shown in Fig. 1 . A total of 186 differentially expressed probe sets showed twofold or larger change on day 5. Of these probes, 82 transcripts were upregulated and 104 transcripts were downregulated. Summaries of major functional groups for up-and downregulated genes are presented in Tables 3 and 4 , respectively.
Transcripts Upregulated on Day 5
Kinase activity. Five kinase activity genes were upregulated two-to threefold including mitogen-activated protein kinase kinase kinase 14 (MAP3K14/NIK), involved in skeletal muscle atrophy via MAPK signaling, and the myostatin receptor activin A receptor type IIB (ACVR2B), belonging to the transforming growth factor-beta (TGF-beta) superfamily and involved in regulating muscle mass (22) .
Cell cycle regulation. Four cell cycle regulation genes were upregulated twofold, including nuclear receptor subfamily 2 group F member 2 (NR2F2), required for muscle proliferation and muscle precursor cell migration (21) .
Transcriptional regulation. Nine transcriptional regulation genes were upregulated two-to threefold, including transducin like enhancer split 1 (TLE1), a transcriptional co-repressor of basic helix-loop-helix proteins (16) known to inhibit the expression of different muscle regulatory factors, and the SLC2A4 regulator required for normal GLUT4 expression and transcriptional regulation via an AMPK-induced mechanism (17). Channel regulation. Three potassium and calcium channel regulation genes were upregulated two-to threefold, i.e., channels reported to be upregulated during other muscle wasting conditions such as ground-based microgravity studies using the hind-limb suspension model (37) .
Proteolytic pathways. The significant upregulation of the ubiquitin proteasome system [the muscle-specific E3 ligase MAFbx (atrogin-1) and Fbxo33] and lysosomal (cathepsins D, B, K, and Z) proteolytic pathway genes observed in response to immobilization and MV (6) did not show any additional change when systemic CS administration was combined with ICU intervention.
Miscellaneous. Nearly 20 miscellaneous genes were upregulated two-to threefold, including interleukin 1 receptor accessory protein (IL1RAP), involved in myogenesis (5), and bone morphogenetic protein 4 (BMP4), positively regulating myotube maturation/formation leading to myogenesis (36) . Also upregulated was four and a half LIM domains 3 (FHL3), a transcriptional co-repressor interacting with myogenic differentiation 1(MyoD) and negatively regulating myogenesis (10). Finally, EIF4EBP1 translational repressor was upregulated in a similar pattern to what has previously been reported in critically ill ICU patients (9) .
Transcripts Downregulated on Day 5
HSPs. Four HSP genes were downregulated two-to threefold, such as heat shock 70 kDa protein 4 (HSPA4) and HSP 90 functional isoforms (HSPCA and HSPCB). This is of specific interest since HSPA4 overexpression has been shown to prevent skeletal muscle atrophy (31) , and HSPCA and HSPCB play important roles in the folding of newly synthesized proteins in the refolding of denatured proteins during stress conditions (7) .
Cytoskeletal and sarcomeric. Eight cytoskeletal and sarcomeric protein genes were downregulated two-to threefold, such as the major molecular motor protein in skeletal muscle, myosin [the ␤/slow type I myosin heavy chain isoform (MYH7)], the slow skeletal muscle troponin T (TNNT1) gene, and the microtubule-associated protein 1A (MAP1A) gene.
Oxidative stress responsive. Two oxidative stress-responsive genes were downregulated three-to fourfold, including thioredoxin reductase 1 (TXNRD1) and superoxide dismutase 2 mitochondrial (SOD2) genes, which are involved in oxidative stress defense (4).
Miscellaneous. Fifteen miscellaneous genes were downregulated two-to sixfold, including histone deacetylase 9 (HDAC9), a transcriptional repressor acting as a direct transcriptional target for the myocyte enhancer factor 2 (MEF2) in vitro and in vivo (15) . EIF4E, which is involved in the translation machinery and its preferred association with endogenous inhibitor 4EBP1, leads to decreased protein synthesis (32) .
Validation of Microarray Data
In accordance with microarray data, real-time RT-PCR showed an upregulation of the following genes: ACVRIIB ( Fig. 2A) and 4EBP1 (Fig. 2B) . Downregulation was confirmed in MYH7 (Fig. 2C), MAP1A (Fig. 2D), and SOD2 (Fig. 2E) . At the protein level, a general decrease was observed in the HSP 70 and HSP 90, and an increase was observed in 4EBP1. A statistically significant increase in Atrogin-1 (Fig. 3) . Data are presented as means Ϯ SD.
DISCUSSION
Severe muscle wasting and weakness in critically ill ICU patients have negative consequences for survival and health care costs with a subsequent negative impact on patient quality of life that persists long after hospital discharge. There is reason to believe that the systemic administration of CS in ICU patients contributes to this impaired muscle function. We have recently shown that the addition of CS in an experimental ICU setting reduced the force-generating capacity (SF) by 30 -40% at the single muscle fiber level in limb muscles (Fig. 4) (26) . In an attempt to further explore the mechanisms underlying the effects of CS on limb muscle function, gene expression analyses were conducted and compared between pigs exposed to 5 days sedation, immobilization, and MV alone or in combination with systemic CS hormone administration. The addition of CS to the ICU intervention resulted in a more than twofold change in 186 differentially expressed probe sets in limb muscle. The specific CS hormone-induced effects on regulation of protein synthesis at the translational level, kinase activity, and HSP gene expression are suggested to play an important role for the impaired regulation of muscle contraction observed in response to CS hormone administration in combination with the ICU intervention. In contrast to our original hypothesis, systemic CS administration did not induce any further upregulation of proteolytic pathways compared with the ICU intervention alone. On the other hand, systemic CS administration had a significant effect on muscle size via other mechanisms, such as a decreased protein synthesis rate at the translational level and upregulation of specific kinases promoting muscle atrophy via different signaling pathways. The upregulation of the 4EBP1 gene and the downregulation of EIF4E and EIF3S3 genes in response to CS administration indicate an inhibition of protein synthesis via the translational machinery. Different kinases were upregulated in response to the CS administration, such as MAP3K14 involved in MAPK signaling and the myostatin receptor (ACVR2B). MAP3K14 promotes muscle wasting via downstream activators of MAPK signaling genes such as growth arrest and DNA damage-inducible (GADD45) and cyclindependent kinase inhibitor 1A (P21). It is of specific interest to note that similar results were reported in response to CS administration in ICU patients (11) , and GADD45a has also been reported to be associated with muscle wasting during fasting, immobilization, and peripheral denervation (12) . Other kinases, such as the receptor of the negative regulator of muscle size, myostatin, ACVR2B, were upregulated in response to systemic CS administration. Furthermore, different transcriptional co-repressor genes involved in the negative regulation of muscle mass such as TLE1 and FHL3 were upregulated. On the other hand, different myogenesis genes including NR2F2, IL1RAP, and BMP4 were upregulated in response to CS administration and may reflect a compensatory mechanism. The obligatory role of NR2F2 has been shown with the conditional knockout studies, which reveal that the loss of this gene leads to hypoplastic skeletal muscle development as well as shorter limbs (21) and that endogenous expression of BMP4 increases the progression of myogenic differentiation in skeletal muscle (36) . A significant downregulation of HSP, cytoskeletal, sarcomeric, and oxidative stress-responsive genes was observed in response to systemic CS hormone administration. HSP play an important role during stress recovery, and at basal levels these HSP act as in-house chaperones. It is of specific interest to note that HSP70 was downregulated in response to the ICU intervention together with CS compared with ICU intervention alone. This result is consistent with our previous studies. First, HSP70 downregulation was observed in response to the ICU intervention and sepsis compared with ICU intervention alone where the addition of sepsis resulted in a lower SF similar to the present study (2) . Second, upregulation of HSP70 was associated with the maintenance of muscle mass and function in the porcine ICU model when animals were only exposed to immobilization, MV, muscle relaxants, and sedation (1, 6) . It has also been shown that HSP70 directly regulates skeletal muscle atrophy via FOXO signaling (30) and that inducible HSP70 overexpression improves skeletal muscle structure and functional capacity (24) .
The molecular motor protein myosin (MYH7), the dominating thick filament protein, has been reported to be downregulated in response to the experimental ICU setting (6, 26) . However, the additional downregulation of MYH7 when CS were added did not alter the myosin-actin ratio or fiber size but was paralleled by a decline in SF. In the rodent ICU model, longer exposure to immobilization, neuromuscular blockers (NMB), sedation, and MV resulted in decreased actin and myosin mRNA expression, a preferential myosin loss, muscle fiber atrophy, and decreased single-fiber SF (27) , i.e., resembling the findings considered pathognomonic for the acquired myopathy observed in critically ill ICU patients (20) . Different oxidative stress-responsive genes like SOD2 and TXNRD1 were downregulated. In our previous gene expression study these oxidative stress-responsive genes were downregulated in response to sepsis (2) . On the other hand, the oxidative stressresponsive genes were upregulated in the masseter muscle of pigs that were mechanically ventilated, sedated, and treated with NMB, sepsis, and CS for 5 days. However, muscle structure and function were maintained in the craniofacial muscle fibers in contrast to limb muscle fibers (1) . Hence, reduced oxidative stress may play an important role in impaired muscle function in the CS-treated pigs by enhancing posttranslational protein modifications and degradation.
Conclusion
Muscle gene expression profiles were studied in response to systemic CS administration in an experimental ICU model over a 5-day period, i.e., pigs exposed to immobilization, sedation, and MV. CS administration in combination with ICU condition resulted in a twofold or larger change in transcriptional regulation of 186 genes compared with animals exposed only to ICU intervention for 5 days. We observed upregulation of kinase activity, cell cycle regulation, and transcriptional regulation genes and downregulation of genes coding heat shock, oxidative stress response, cytoskeletal, and sarcomeric proteins. While the mechanisms underlying CS-induced decline in muscle fiber force generation capacity in animals exposed to ICU intervention are complex, the CS-induced changes in the gene expression of kinase activity, HSP, and oxidative stress response genes are presented as critical factors. By targeting these genes future experiments may provide an important clinical avenue aiming at protecting muscle mass and function in critically ill ICU patients. 
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